Monopar Therapeutics Inc
NASDAQ:MNPR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Monopar Therapeutics Inc
NASDAQ:MNPR
|
US |
|
Capricor Therapeutics Inc
NASDAQ:CAPR
|
US |
|
C
|
CDW Corp
XBER:CDW
|
US |
DCF Value
The DCF Value for
Monopar Therapeutics Inc (MNPR) under the Base Case is 14.06 USD.
Compared with the current market price of 115.44 USD, the stock appears
Overvalued by 88% .
DCF Model
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more